Y-mabs to host annual research and development day in new york

New york, dec. 06, 2022 (globe newswire) -- y-mabs therapeutics, inc. (the “company” or “y-mabs”) (nasdaq: ymab) a commercial-stage biopharmaceutical company today announced that it will host its annual research and development day in new york, ny on december 14, 2022, at 9:00 am et. the event will feature presentations of the company, its clinical development, and advanced product pipeline.

YMAB Ratings Summary

YMAB Quant Ranking